Community-acquired pneumonia - PubMed (original) (raw)

Review

Community-acquired pneumonia

Ricardo J José et al. Curr Opin Pulm Med. 2015 May.

Abstract

Purpose of review: Community-acquired pneumonia (CAP) is the most common infectious disease cause of death. We summarize recent findings regarding the epidemiology of CAP in adults, efficacy of vaccines against Streptococcus pneumoniae, diagnostics, and discuss the current controversy between CAP and healthcare-associated pneumonia (HCAP).

Recent findings: The emergence of the Middle East respiratory syndrome coronavirus and the avian influenza A strain H7N9 are of concern but still these are infrequent causes of CAP. Recent data indicate that vaccinating children also protects adults against CAP by generating significant herd immunity, and that the conjugated pneumococcal vaccine in adults may offer some efficacy in preventing CAP caused by vaccine serotypes. The immunochromotagraphic urinary antigen test has improved the diagnostic yield for the aetiology of CAP, and initial data demonstrate that a novel multiplex urinary antigen test will further increase the sensitivity for detection of S. pneumoniae. There has been significant concern that a relatively recently described pneumonia category, HCAP, requires empirical treatment for potentially multidrug-resistant organisms (MDRO). However, new evidence shows that (at least in Europe) pneumonia caused by MDRO remains uncommon even in HCAP category patients.

Summary: CAP remains a major cause of morbidity and mortality. Advances in vaccination and diagnosis should help reduce the amount of disease due to S. pneumoniae, the commonest cause of CAP. Outside of the United States, MDRO are relatively uncommon causes of CAP, and the increased mortality of HCAP category patients seems to be related to their comorbidities and age rather than microbial aetiology.

PubMed Disclaimer

Cited by

Peptidoglycan Recognition Protein 2 Regulates Neutrophil Recruitment Into the Lungs After Streptococcus pneumoniae Infection.
Dabrowski AN, Conrad C, Behrendt U, Shrivastav A, Baal N, Wienhold SM, Hackstein H, N'Guessan PD, Aly S, Reppe K, Suttorp N, Zahlten J. Dabrowski AN, et al. Front Microbiol. 2019 Feb 19;10:199. doi: 10.3389/fmicb.2019.00199. eCollection 2019. Front Microbiol. 2019. PMID: 30837960 Free PMC article.
Pneumolysin induced mitochondrial dysfunction leads to release of mitochondrial DNA.
Nerlich A, Mieth M, Letsiou E, Fatykhova D, Zscheppang K, Imai-Matsushima A, Meyer TF, Paasch L, Mitchell TJ, Tönnies M, Bauer TT, Schneider P, Neudecker J, Rückert JC, Eggeling S, Schimek M, Witzenrath M, Suttorp N, Hippenstiel S, Hocke AC. Nerlich A, et al. Sci Rep. 2018 Jan 9;8(1):182. doi: 10.1038/s41598-017-18468-7. Sci Rep. 2018. PMID: 29317705 Free PMC article.
Inappropriate Use of Antimicrobials for Lower Respiratory Tract Infections in Elderly Patients: Patient- and Community-Related Implications and Possible Interventions.
van Heijl I, Schweitzer VA, Zhang L, van der Linden PD, van Werkhoven CH, Postma DF. van Heijl I, et al. Drugs Aging. 2018 May;35(5):389-398. doi: 10.1007/s40266-018-0541-7. Drugs Aging. 2018. PMID: 29663151 Free PMC article.
Pneumococcal Vaccination in Immunocompromised Hosts: An Update.
Froneman C, Kelleher P, José RJ. Froneman C, et al. Vaccines (Basel). 2021 May 21;9(6):536. doi: 10.3390/vaccines9060536. Vaccines (Basel). 2021. PMID: 34063785 Free PMC article. Review.
Corynebacterium Species Inhibit Streptococcus pneumoniae Colonization and Infection of the Mouse Airway.
Horn KJ, Jaberi Vivar AC, Arenas V, Andani S, Janoff EN, Clark SE. Horn KJ, et al. Front Microbiol. 2022 Jan 10;12:804935. doi: 10.3389/fmicb.2021.804935. eCollection 2021. Front Microbiol. 2022. PMID: 35082772 Free PMC article.

Community-acquired pneumonia - PubMed (original) (raw)